期刊文献+

体外连接法构建重组人γ干扰素腺病毒并检测其在真核细胞中的表达 被引量:3

Construction of Recombinant Adenovirus Carrying Human IFNγ Gene by In Vitro Ligation and Its Expression
下载PDF
导出
摘要 背景与目的:γ干扰素(interferon-γ,IFNγ)具有直接促进某些肿瘤细胞凋亡和调节细胞免疫的功能,因此在肿瘤的基因治疗中IFNγ将发挥重要的作用。本研究构建携带人IFNγcDNA的重组腺病毒,并检测它在真核细胞中的表达。方法:用逆转录聚合酶链反应(reversetranscription-polymerasechainreaction,RT-PCR)从人外周血单个核细胞中扩增出IFNγ的cDNA全长序列,插入腺病毒穿梭质粒pShuttle,经酶切和DNA测序鉴定,然后用体外连接法构建重组腺病毒Ad-IFNγ。用所构建的重组Ad-IFNγ感染HepG2细胞,通过RT-PCR和免疫组织化学法检测IFNγ的表达。结果:经测序,克隆的人IFNγcDNA序列与GenBank上公布的序列完全一致;Ad-IFNγ感染的HepG2细胞在转录和翻译水平均有IFNγ的表达。结论:体外连接法是一种简便易行的重组腺病毒载体构建方法;所构建的重组腺病毒Ad-IFNγ能表达IFNγ蛋白,可用于抗肿瘤和抗病毒等细胞及动物实验。 BACKGROUND & OBJECTIVE: Interferon-γ (IFNγ) can promote directly the apoptosis of some kinds of tumor ceils and regulate cellular immunity, therefore, it may play an important role in gene therapy for tumors. This study was to construct recombinant adenovirus carrying human IFNγ cDNA, and detect its expression profile in eukaryotic cells. METHODS: IFNγ cDNA was amplified by reverse transcription-polymerase chain reaction (RT-PCR) from human peripheral blood mononuclear cells, and cloned into adenoviral shuttle plasmid pShuttle to construct recombinant adenovirus carrying human IFNγ cDNA (Ad-IFNγ) by in vitro ligation. Hepatocellular carcinoma cell line HepG2 was infected with Ad-IFNγ, and the expression of IFNγ was detected by RT-PCR and immunohistochemistry. RESULTS: The sequence of the cloned IFNγ cDNA was completely consistent with that reported in GenBank. PCR analysis confirmed the existence of IFNγ gene in Ad-IFNγ without wild adenovirus contamination, and the genome of Ad-IFNγ showed the predicted map of restricted endonuclease enzymes analysis. IFNγ mRNA and protein were detected in HepG2 cells infected with Ad-IFNγ. CONCLUSIONS: In vitro ligation is a simple and convenient method for construction of recombination adenovirus vector. We have constructed a functional recombinant adenovirus expressing human IFNγ, which could be a potential antivirus and antitumor agent in vitro or in vivo.
出处 《癌症》 SCIE CAS CSCD 北大核心 2006年第6期771-774,共4页 Chinese Journal of Cancer
基金 广东省医学科学技术研究基金资助(No.B2002050) 国家基础研究计划(973)资助(No.2004CB518801) 广东省科委重大攻关项目资助(No.2003A10902)~~
关键词 肿瘤 基因治疗 IFNΓ 体外连接法 腺病毒载体 表达 Neoplasm Gene therapy interferon-γ (IFNγ) In vitro ligation Adenoviral vector Expression
  • 相关文献

参考文献6

  • 1Gray P W,Leung D W,Pennica D,et al.Expression of human immune interferon cDNA in E.coli and monkey cells[J].Nature,1982,295 (5849):503-508.
  • 2张艳玲,刘然义,柯妙拉,陈洁敏,李晓红,叶春玲,黄文林.壳蛋白免疫法测定重组腺病毒滴度的方法学评价[J].中国病理生理杂志,2005,21(4):830-832. 被引量:9
  • 3Huang W,Flint S.Unusual properties of adenovirus E2E transcription by RNA polymerase Ⅲ[J].J Virol,2003,77(7):4015-4024.
  • 4Mizuguchi H,Kay M A.Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method[J].Hum Gene Ther,1998,9(17):2577-2583.
  • 5Boehm U,Klamp T,Groot M,et al.Cellular responses to interferon-gamma[J].Annu Rev Immunol,1997,15:749-795.
  • 6Shankaran V,Ikeda H,Bruce A T,et al.IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity[J].Nature,2001,410(6832):1107-1111.

二级参考文献4

  • 1Marcel T, Grausz JD. The TMC worldwide gene therapy enrollment report, end 1996[J]. Hum Gene Ther, 1997, 8(6):775-800.
  • 2Hitt DC, Booth JL, Dandapani V, et al. A flow cytometric protocol for tittering recombinant adenoviral vectors containing the green fluorescent protein[ J]. Mol Biotechol, 2000, 14(3): 197-203.
  • 3David T, Curiel T, Agarwal S, et al. Adenovirus enhancement of transferring-polylysine-mediated gene delivery[ J].Proc Natl Acad Sci USA, 1991, 88: 8850-8854.
  • 4Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy [J]. J Virol, 1996, 70(11): 7498-7509.

共引文献8

同被引文献18

  • 1张艳林,薛刚.肿瘤细胞裂解物致敏的树突状细胞对肝癌HepG2细胞杀伤的体外研究[J].华西医学,2007,22(1):18-19. 被引量:4
  • 2Lo J C, Chin R K, Lee Y, et al. Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues[ J ]. J Clin Invest, 2003, 112 (10) : 1495 - 1505.
  • 3Takeuchi H, Fujimoto A, Tanaka M, et al. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells[ J]. Clin Cancer Res, 2004, 10(7) : 2351 -2358.
  • 4Ng P, Parks R J, Cummings D T, et al. An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method [J]. Hum Gene Ther, 2000, 11 (5) : 693 - 699.
  • 5Sharma S, Stolina M, Luo J, et al. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo [J]. J Immunol, 2000, 164(9) : 4558 -4563.
  • 6Sharmna S, Stolina M, Zhu L, et al. Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous nmrinc bronchoalveolar cell carcinoma[ J]. Cancer Res, 2001,61 (17) : 6406 - 6412.
  • 7Nishimura N, Nishioka Y, Shinohara T, et al. Novel centrifugal method for simple and highly efficient adenovirus- mediated green fluorescence pmteingene transduction into human monocyte-derived dendritic cells [ J ]. J Immunol Methods, 2001,253(1 -2) :113 - 124..
  • 8Lodge P, Jones L, Bader R, et al. Dendritic cell based immunotherapy of prostate cancer : immune monitoring of a phase Ⅱ clinical trial[ J]. Cancer Res, 2000,60(4) :829 - 833.
  • 9Pan J, Zhang M, Wang J, et al. Interferon-γ is an autocrine mediator for dendritic cell maturation [ J ] . Immunol Lett, 2004, 94(1 -2): 141 -151.
  • 10Rodolfo M, Colombo MP. Interleukin- 12 as an Adjuvant for cancer immunotherapy [ J] . Methods, 1999 , 19 ( 1 ) : 114 - 120.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部